Publication | Open Access
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies
39
Citations
26
References
2023
Year
None.
| Year | Citations | |
|---|---|---|
Page 1
Page 1